Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical company owned by the Saudi sovereign wealth fund PIF (Public Investment Fund), to ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...